Hear From Cancer Research and Life Foundation Patients
See Patient Stories.
A LITTLE BIT MORE
About Us
The Cancer Research and Life foundation is unique in providing cancer patients with immediate help wherever they are in their cancer treatment experience, by providing education, guidance, and access to research-based treatments, and beyond. Each and every patient who seeks our help, finds a meaningful solution to ease the journey.
Learn More
Our Mission
Our mission is to “improve cancer patient’s response and quality of care, while receiving therapies both in conventional and/or research settings”..
Learn more
Research
Advancements in research are critical to provide optimal treatment option for patients while reducing the debilitating side effects of various..
Learn more
Get Involved
There are plenty sponsorship opportunities at CRL Foundation. As one organization provides assistance to reduce costs..
Learn more
WE ARE FIGHTING FOR
Recent Causes
MEET OUR STAFF
Our wonderful staff in both CRL Foundation, are trained and caring for every patient. Both offices in Central and South California are available for patients nationwide. .
CUTTING EDGE TREATMENT
At the CRL Foundation, we are trained to provide complementary and Integrative treatments to patients diagnosed with cancer.
YOUR LIFE DOESN’T STOP WHEN YOU HAVE CANCER
Cancer impacts each persons’ life very differently. These issues can be related to all areas of your life including your body, mood,..
WORKING TO SAVE WORLD
Meet The Team
EVERYTHING CHANGES
Notes From President
1st August 2015
Nezami, M.A., Stobbe, D., & Gould-Simon, A.
Angiogenesis: cause or effect? Companion diagnostics and surrogate markers for a novel antiangiogenic therapy multitargeted epigenetic therapies (MTET).
November 2005
Jadvar, H., Xu, A., Tumeh, P., Pollock, J., & Nezami, M.
Surveillance and Management of Lymphoma with Serial FDG PET-CT. Retrieved August 07, 2017
2015
Nezami, M. A., Stobbe, D., Gould-Simon, A.
Prognostic surrogate markers for survival, a case series for a novel antiangiogenic therapy (multitargeted epigenetic therapies/MTET). Pancreatic Cancer Symposium, POSTER A39.